Lancet Hiv's 2026 Journal Metrics Score is 5.3, ranking Q1 in Infectious Diseases and 2 other subfields. Two-year citation average from OpenAlex data, updated August 2026.
Bookmark this page — track observed submission-to-acceptance timing, FWCI and field-normalized citation data for this journal in one view.
Journal Metrics Score 2026 · 2021–2024 window citedness 5.19.
Middle 50%: 15–136 days
75 of 100 PubMed-indexed articles · 75% coverage · 2024–2025
Lancet Hiv accepts papers a median of 83 days after submission, including peer review and revisions. That is faster than 74% of comparable journals with PubMed timing data.
Journal-level estimate only. Verify current charges, taxes, waivers, discounts, and article-type fees with the journal.
Paste your title to see which of this journal's published topics it overlaps with. Your title stays in your browser for this preview and is not sent anywhere.
Want ranked journals with fit reasons, risks and a submission strategy instead? See a sample AI report.
Each spoke is a 0–100 percentile within a comparable journal cohort—not a percentage grade or a single black-box rating.
202 of 698 works · same type, year & subfield
34 works · same type, year & subfield
Below field-year expectation
of 4,234 topic-associated OpenAlex sources by lifetime output
FWCI compares papers with the same publication year, type, and field. 1.0 is the world average; above 1.0 is above expectation. This journal's median is 0.84, so its typical recent paper runs about 16% below its field benchmark.
28.9% of recent papers rank in the global top 10% after field normalization. This is easier to compare across specialties than raw citation totals.
Volume is separated from citation accumulation so newer papers are not presented as weaker simply because they are newer.
OpenAlex source records · 2016–2025
698 OpenAlex works · 2021–2024
OpenAlex topics show research communities; MeSH keeps the medical taxonomy recognizable.
Select a MeSH signal to see how much Lancet Hiv publishes on it, from PubMed counts for the last five complete years.
Candidates share at least one OpenAlex subfield (or field, if too few do) with this journal's main research topics, ignoring generic catch-all topics, and are ordered by topic overlap, then current Journal Metrics Score.
* Cost is indicative only. APCs, taxes, waivers, and member discounts can change—always verify on the journal's official website.
| Category | Quartile |
|---|---|
| Infectious Diseases | Q1 |
| Epidemiology | Q1 |
| Virology | Q1 |
Yes. A Q1 journal by citation data
Yes. By citation data, Lancet Hiv is a strong journal: it is Q1 in Infectious Diseases and 2 other subfields and ranks #456 of 6,272 Medicine journals by Journal Metrics Score (top 8%). Lancet Hiv's 2026 Journal Metrics Score is 5.3. Recent papers took a median of 83 days from submission to acceptance, according to PubMed dates. OpenAlex lists an indicative article processing charge of $7,280 USD. OpenAlex classifies its papers in subfields including Infectious Diseases, Epidemiology, and Virology, so check that your topic fits its scope.
Verdict from citation data only: quartile and field rank by Journal Metrics Score (OpenAlex), publisher-reported acceptance rates, and PubMed submission and acceptance dates. See how we rank journals and how to verify indexing.
Confirm the exact title and ISSNs against the publisher homepage before a high-stakes submission decision.
2026 Journal Metrics Scores for 13 of 21 Lancet journals published by Elsevier BV, highest score first. Each journal is scored separately; there is no combined score for the Lancet family.
Source: the current OpenAlex source record. OpenAlex works can include multiple work types. Fully Open Access is a source-level flag. Recent OA Works is summed from OpenAlex's counts_by_year series (up to the latest ten years); it is not a lifetime OA percentage. Any APC shown here is an indicative OpenAlex value—verify current charges on the journal's official website.
OpenAlex classifies Lancet Hiv's papers in subfields including Infectious Diseases, Epidemiology, and Virology. Read the aims and scope page and a few recent papers close to your topic before you prepare the manuscript.
Article types, word and figure limits, reference style, and the required statements (data availability, ethics, conflicts of interest, author contributions) are set by the journal. Prepare the cover letter and files to match them.
Lancet Hiv homepage ↗Most Elsevier and Cell Press journals take submissions through Editorial Manager; each journal has its own site, reached from Submit your article on the journal homepage.
OpenAlex lists an indicative article processing charge of $7,280 USD. Check the current fee, waivers, and any institutional agreement on the journal website.
Recent accepted papers took a median of 83 days from submission to acceptance, including revisions (PubMed dates). Lancet Hiv does not publish an acceptance rate.
Submission system from the publisher's author information, checked 2026-10-27. Individual journals can differ, so follow the link in the journal's own author guidelines.
New on PubMed
Type a topic to see the newest PubMed papers from the past week and the big picture of what they found, summarized by Claude on the Pro plan. Get a free weekly email to keep up.
See a demo:GLP-1CRISPRLong COVID
Reviewer Two · coming soon
An AI pre-submission report on your manuscript: the objections a tough reviewer is likely to raise, desk-rejection risks, and better-fit journals from our data. $29 per report.
See what the report coversYes. By citation data, Lancet Hiv is a strong journal: it is Q1 in Infectious Diseases and 2 other subfields and ranks #456 of 6,272 Medicine journals by Journal Metrics Score (top 8%). Lancet Hiv's 2026 Journal Metrics Score is 5.3. Recent papers took a median of 83 days from submission to acceptance, according to PubMed dates. OpenAlex lists an indicative article processing charge of $7,280 USD. OpenAlex classifies its papers in subfields including Infectious Diseases, Epidemiology, and Virology, so check that your topic fits its scope.
Lancet Hiv's 2026 Journal Metrics Score is 5.3, from the August 2026 data release. The score is a two-year citation average computed from OpenAlex (CC0) data: citations received in the most recent complete year to works published in the two prior years, divided by the number of those works.
We have not found an official acceptance rate published by Lancet Hiv or its publisher, and Journal Metrics does not estimate one because submission counts are not public. What recent PubMed records do show is speed: accepted papers took a median of 83 days from submission to acceptance. To judge selectivity, compare Lancet Hiv's quartile and score with similar journals, or ask the editorial office.
Lancet Hiv's best quartile is Q1. By OpenAlex subfield: Q1 in Infectious Diseases; Q1 in Epidemiology; Q1 in Virology. Quartiles rank journals by Journal Metrics Score within each subfield.
No. Journal Metrics computes the score independently from OpenAlex open data. Other providers use different citation databases, document types, and counting rules, so their published figures for Lancet Hiv will not match this score exactly. Compare journals using one source at a time.
Lancet Hiv accepts papers a median of 83 days after submission across 75 recent PubMed records with both dates; the middle half took 15–136 days. This includes peer review, editorial handling, and revisions.
PubMed records when a manuscript was received and accepted, not the individual review stages, so peer review time on its own is not available. The full time from submission to acceptance at Lancet Hiv, which includes peer review and revisions, has a median of 83 days. For the time to a first decision, check the journal's own website.
Lancet Hiv's median of 83 days from submission to acceptance is faster than 74% of comparable journals with PubMed timing data.
OpenAlex lists an indicative article processing charge of $7,280 USD for Lancet Hiv. This journal-level estimate may exclude taxes, waivers, discounts, or article-type fees, so confirm the current charge on the journal's website.
Comparable journals include Journal of the International Aids Society, Aids Patient Care and Stds, Hiv Aids-Research and Palliative Care, and Jaids-Journal of Acquired Immune Deficiency Syndromes. Compare their scores, acceptance times, and costs in the recommended alternatives on this page before choosing where to submit.
Most Elsevier and Cell Press journals take submissions through Editorial Manager; each journal has its own site, reached from Submit your article on the journal homepage. Before submitting, check the scope, follow the author guidelines for article type, length, and required statements, and prepare a cover letter. Accepted papers took a median of 83 days from submission to acceptance in recent PubMed records.